BIO VIEW LTD 

$0.9666
0
+$0.00+0% Tuesday 20:00

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Dividends

0%Dividend Yield
Apr 17
$0.55
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

30SepExpected
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Q4 2020
Q1 2021
Q2 2021
-0.01
0
0.02
0.04
Expected EPS
N/A
Actual EPS
0.0248

Financials

0.99%Profit Margin
Profitable
2018
2019
2020
2021
2022
2023
9.52MRevenue
94,644.32Net Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Bio-View Ltd, founded in 2000 and headquartered in Rehovot, Israel, is a developer, manufacturer, and global distributor of advanced automated cell imaging and analysis systems. These sophisticated solutions are utilized by clinical and research laboratories worldwide, specifically in the fields of cytology, cytogenetics, and pathology. The company's extensive product lineup includes: Accord: A semi-automated fluorescent imaging and analysis workbench microscope station. Accord Plus: An automatic fluorescent imaging system capable of real-time scanning, analysis, and sorting of diverse FISH (Fluorescence In Situ Hybridization) samples. Allegro Plus: Another automatic fluorescent imaging system engineered to pinpoint various chromosomal aberrations under fluorescent light, such as amplifications, translocations, inversions, and deletions. DUET-3: An imaging and analysis platform featuring an automated barcode reader, which streamlines the processing of multiple test types within a single scan batch. DeNovo: An automated scanning system dedicated to the precise detection, analysis, and characterization of circulating tumor cells found in peripheral blood. Solo Workstation & Solo Touch Workstation: These are offline and standalone workstations, respectively, providing advanced tools for reviewing and analyzing test results remotely from the microscope. SoloWeb: A comprehensive web-based solution that enables remote analysis, reporting, and expert consultation on cases scanned using Bio-View's systems. Furthermore, Bio-View Ltd has established a strategic partnership with ANGLE plc to jointly develop a liquid biopsy circulating tumor cell HER2 assay, specifically targeting breast cancer.
Show more...
CEO
Daniel Klain
Employees
30
Country
Israel

Listings

0 Comments

Share your thoughts

FAQ

What is BIO VIEW LTD stock price today?
The current price of BIVWF is $0.97 USD — it has increased by +0% in the past 24 hours. Watch BIO VIEW LTD stock price performance more closely on the chart.
What is BIO VIEW LTD stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on PINK exchange BIO VIEW LTD stocks are traded under the ticker BIVWF.
What were BIO VIEW LTD earnings last quarter?
BIVWF earnings for the last quarter are 0.02 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is BIO VIEW LTD revenue for the last year?
BIO VIEW LTD revenue for the last year amounts to 9.52M USD.
What is BIO VIEW LTD net income for the last year?
BIVWF net income for the last year is 94,644.32 USD.
Does BIO VIEW LTD pay dividends?
Yes, BIVWF dividends are paid annual. The last dividend per share was 0.55 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does BIO VIEW LTD have?
As of August 30, 2026, the company has 30 employees.
In which sector is BIO VIEW LTD located?
BIO VIEW LTD operates in the Health & Wellness sector.
When did BIO VIEW LTD complete a stock split?
The last stock split for BIO VIEW LTD was on December 24, 2023 with a ratio of 1:10.
Where is BIO VIEW LTD headquartered?
BIO VIEW LTD is headquartered in Rehovot, Israel.